Oral cancer treatments and compliance : MEMS® assessment for capecitabine, letrozole and exemestane

Autoria(s): Achtari Jeanneret, L.; Luthi, F.; Guignard Hefti, E.; Schneider, M.P.; Lange, A.C.; Pachinger, C.; Montemurro, M.; Bauer, J.; Naoux, R.; Bugnon, O.; Leyvraz, S.
Data(s)

2010
Identificador

https://serval.unil.ch/notice/serval:BIB_41D740D4CBB6

https://serval.unil.ch/resource/serval:BIB_41D740D4CBB6.P001/REF

http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_41D740D4CBB62

urn:nbn:ch:serval-BIB_41D740D4CBB62
Idioma(s)

eng
Direitos

info:eu-repo/semantics/openAccess

Copying allowed only for non-profit organizations

https://serval.unil.ch/disclaimer
Fonte

Berlin 2009 Congress, European Society for Medical Oncology (ESMO)
Tipo

info:eu-repo/semantics/conferenceObject

inproceedings
Formato

application/pdf
Acesso ao item digital